Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz, René dePont Christensen, Zoltán Novàk, Destin R. Black, Lucy Gilbert, Sudarshan Kumar Sharma, Giorgio Valabrega, Lisa Michelle Landrum, Lars Hanker, Ashley R. Stuckey, Ingrid A Boere, Michael A. Gold, Annika Auranen, Bhavana Pothuri, David Cibula, Carolyn Kay McCourt, Francesco Raspagliesi, Mark S. Shahin, Sarah E. Gill, Bradley J. Monk, Joseph Buscema, Thomas J. Herzog, Larry J. Copeland, and 6 more
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1056/nejmoa2216334
- Published
- Mar 27, 2023
- Venue
- New England Journal of Medicine
- DOI
- 10.1056/nejmoa2216334
- PubMed
- 36972026
- Categories
- Endometrial and Cervical Cancer Treatments
- License
- other-oa
- Provenance
- openalex